Avidity
Brian Slama is an experienced professional in the biopharmaceutical industry, currently serving as the National Account Director at Avidity Biosciences, Inc. since April 2025. Prior to this role, Slama held positions including Gene Therapy National Account Director at bluebird bio and Account Executive at Oncopeptides AB. With a robust background in account management and market access across various organizations such as MorphoSys, Novartis, and Merck, Slama has demonstrated expertise in key account management, product launches, and reimbursement processes. Slama's career also includes significant experience in sales management and team leadership in companies like Stryker and Ortho Biotech, Johnson & Johnson. A graduate of Ball State University with a BA in English, Slama has consistently driven business growth and strengthened customer relationships throughout a dynamic career in healthcare sales.
This person is not in any teams
This person is not in any offices
Avidity
2 followers
Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.